Moderna Statistics
Total Valuation
Moderna has a market cap or net worth of EUR 9.35 billion. The enterprise value is 2.69 billion.
Market Cap | 9.35B |
Enterprise Value | 2.69B |
Important Dates
The next estimated earnings date is Thursday, July 31, 2025.
Earnings Date | Jul 31, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | 386.74M |
Shares Outstanding | n/a |
Shares Change (YoY) | +1.05% |
Shares Change (QoQ) | +0.26% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 360.98M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 3.18 |
PB Ratio | 1.00 |
P/TBV Ratio | 1.01 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -0.86 |
EV / Sales | 0.97 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -0.72 |
Financial Position
The company has a current ratio of 4.22, with a Debt / Equity ratio of 0.07.
Current Ratio | 4.22 |
Quick Ratio | 3.92 |
Debt / Equity | 0.07 |
Debt / EBITDA | n/a |
Debt / FCF | -0.19 |
Interest Coverage | -196.26 |
Financial Efficiency
Return on equity (ROE) is -29.34% and return on invested capital (ROIC) is -18.75%.
Return on Equity (ROE) | -29.34% |
Return on Assets (ROA) | -15.84% |
Return on Invested Capital (ROIC) | -18.75% |
Return on Capital Employed (ROCE) | -33.59% |
Revenue Per Employee | 506,786 |
Profits Per Employee | -535,499 |
Employee Count | 5,800 |
Asset Turnover | 0.22 |
Inventory Turnover | 27.39 |
Taxes
Income Tax | -45.33M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -82.94% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -82.94% |
50-Day Moving Average | 23.56 |
200-Day Moving Average | 39.12 |
Relative Strength Index (RSI) | 51.53 |
Average Volume (20 Days) | 55,505 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 6.15 |
Income Statement
In the last 12 months, Moderna had revenue of EUR 2.94 billion and -3.11 billion in losses. Loss per share was -8.07.
Revenue | 2.94B |
Gross Profit | -2.42B |
Operating Income | -3.45B |
Pretax Income | -3.15B |
Net Income | -3.11B |
EBITDA | -3.27B |
EBIT | -3.45B |
Loss Per Share | -8.07 |
Balance Sheet
The company has 5.53 billion in cash and 689.27 million in debt, giving a net cash position of 7.08 billion.
Cash & Cash Equivalents | 5.53B |
Total Debt | 689.27M |
Net Cash | 7.08B |
Net Cash Per Share | n/a |
Equity (Book Value) | 9.31B |
Book Value Per Share | 24.06 |
Working Capital | 4.78B |
Cash Flow
In the last 12 months, operating cash flow was -2.82 billion and capital expenditures -899.29 million, giving a free cash flow of -3.72 billion.
Operating Cash Flow | -2.82B |
Capital Expenditures | -899.29M |
Free Cash Flow | -3.72B |
FCF Per Share | n/a |
Margins
Gross margin is -82.37%, with operating and profit margins of -117.37% and -105.67%.
Gross Margin | -82.37% |
Operating Margin | -117.37% |
Pretax Margin | -107.21% |
Profit Margin | -105.67% |
EBITDA Margin | -111.33% |
EBIT Margin | -117.37% |
FCF Margin | n/a |
Dividends & Yields
Moderna does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -1.05% |
Shareholder Yield | n/a |
Earnings Yield | -33.23% |
FCF Yield | -39.84% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Moderna has an Altman Z-Score of 7.39 and a Piotroski F-Score of 2.
Altman Z-Score | 7.39 |
Piotroski F-Score | 2 |